Related Articles for PubMed (Select 18373870)

The estrogen and c-Myc target gene HSPC111 is over-expressed in breast cancer and associated with poor patient outcome.

Butt AJ, Sergio CM, Inman CK, Anderson LR, McNeil CM, Russell AJ, Nousch M, Preiss T, Biankin AV, Sutherland RL, Musgrove EA.

Breast Cancer Res. 2008;10(2):R28. Epub 2008 Mar 29.

PMID: 18373870 [PubMed - indexed for MEDLINE]

Related Articles Free article in PMC

c-Myc overexpression and endocrine resistance in breast cancer.

McNeil CM, Sergio CM, Anderson LR, Inman CK, Eggleton SA, Murphy NC, Millar EK, Crea P, Kench JG, Alles MC, Gardiner-Garden M, Ormandy CJ, Butt AJ, Henshall SM, Musgrove EA, Sutherland RL.

J Steroid Biochem Mol Biol. 2006 Dec;102(1-5):147-55. Epub 2006 Oct 18.

PMID: 17052904 [PubMed - indexed for MEDLINE]

Identification of downstream targets of estrogen and c-myc in breast cancer cells.

Musgrove EA, Sergio CM, Anderson LR, Inman CK, McNeil CM, Alles MC, Gardiner-Garden M, Ormandy CJ, Butt AJ, Sutherland RL.

Adv Exp Med Biol. 2008;617:445-51.

PMID: 18497068 [PubMed - indexed for MEDLINE]

c-Myc suppresses p21WAF1/CIP1 expression during estrogen signaling and antiestrogen resistance in human breast cancer cells.

Mukherjee S, Conrad SE.

J Biol Chem. 2005 May 6;280(18):17617-25. Epub 2005 Mar 8.

PMID: 15757889 [PubMed - indexed for MEDLINE]

C-myc gene expression alone is sufficient to confer resistance to antiestrogen in human breast cancer cells.

Venditti M, Iwasiow B, Orr FW, Shiu RP.

Int J Cancer. 2002 May 1;99(1):35-42.

PMID: 11948489 [PubMed - indexed for MEDLINE]

Down-regulation and growth inhibitory role of C/EBPalpha in breast cancer.

Gery S, Tanosaki S, Bose S, Bose N, Vadgama J, Koeffler HP.

Clin Cancer Res. 2005 May 1;11(9):3184-90.

PMID: 15867211 [PubMed - indexed for MEDLINE]

Correlation of amplification and overexpression of the c-myc oncogene in high-grade breast cancer: FISH, in situ hybridisation and immunohistochemical analyses.

Blancato J, Singh B, Liu A, Liao DJ, Dickson RB.

Br J Cancer. 2004 Apr 19;90(8):1612-9.

PMID: 15083194 [PubMed - indexed for MEDLINE]

The c-Myc oncogene directly induces the H19 noncoding RNA by allele-specific binding to potentiate tumorigenesis.

Barsyte-Lovejoy D, Lau SK, Boutros PC, Khosravi F, Jurisica I, Andrulis IL, Tsao MS, Penn LZ.

Cancer Res. 2006 May 15;66(10):5330-7.

PMID: 16707459 [PubMed - indexed for MEDLINE]

Inhibition of c-myc expression by phosphorothioate antisense oligonucleotide identifies a critical role for c-myc in the growth of human breast cancer.

Watson PH, Pon RT, Shiu RP.

Cancer Res. 1991 Aug 1;51(15):3996-4000.

PMID: 1855215 [PubMed - indexed for MEDLINE]

10:

Mechanisms of growth arrest by c-myc antisense oligonucleotides in MCF-7 breast cancer cells: implications for the antiproliferative effects of antiestrogens.

Carroll JS, Swarbrick A, Musgrove EA, Sutherland RL.

Cancer Res. 2002 Jun 1;62(11):3126-31.

PMID: 12036924 [PubMed - indexed for MEDLINE]

11:

Genes regulated by estrogen in breast tumor cells in vitro are similarly regulated in vivo in tumor xenografts and human breast tumors.

Creighton CJ, Cordero KE, Larios JM, Miller RS, Johnson MD, Chinnaiyan AM, Lippman ME, Rae JM.

Genome Biol. 2006;7(4):R28. Epub 2006 Apr 7.

PMID: 16606439 [PubMed - indexed for MEDLINE]

Related Articles Free article in PMC

12:

Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.

Huang H, Groth J, Sossey-Alaoui K, Hawthorn L, Beall S, Geradts J.

Clin Cancer Res. 2005 Jun 15;11(12):4357-64.

PMID: 15958618 [PubMed - indexed for MEDLINE]

13:

Survival signals generated by estrogen and phospholipase D in MCF-7 breast cancer cells are dependent on Myc.

Rodrik V, Zheng Y, Harrow F, Chen Y, Foster DA.

Mol Cell Biol. 2005 Sep;25(17):7917-25.

PMID: 16107734 [PubMed - indexed for MEDLINE]

Related Articles Free article in PMC

14:

Modulation by phenylacetate of early estrogen-mediated events in MCF-7 breast cancer cells.

Liu J, Li J, Sidell N.

Cancer Chemother Pharmacol. 2007 Feb;59(2):217-25.

PMID: 16738884 [PubMed - indexed for MEDLINE]

15:

Glucocorticoid receptor-induced MAPK phosphatase-1 (MPK-1) expression inhibits paclitaxel-associated MAPK activation and contributes to breast cancer cell survival.

Wu W, Pew T, Zou M, Pang D, Conzen SD.

J Biol Chem. 2005 Feb 11;280(6):4117-24. Epub 2004 Dec 7.

PMID: 15590693 [PubMed - indexed for MEDLINE]

16:

Growth factor-dependent regulation of survivin by c-myc in human breast cancer.

Cosgrave N, Hill AD, Young LS.

J Mol Endocrinol. 2006 Dec;37(3):377-90.

PMID: 17170079 [PubMed - indexed for MEDLINE]

17:

Protein expression and molecular analysis of c-myc gene in primary breast carcinomas using immunohistochemistry and differential polymerase chain reaction.

Naidu R, Wahab NA, Yadav M, Kutty MK.

Int J Mol Med. 2002 Feb;9(2):189-96.

PMID: 11786932 [PubMed - indexed for MEDLINE]

18:

Stimulatory cross-talk between NFAT3 and estrogen receptor in breast cancer cells.

Zhang H, Xie X, Zhu X, Zhu J, Hao C, Lu Q, Ding L, Liu Y, Zhou L, Liu Y, Huang C, Wen C, Ye Q.

J Biol Chem. 2005 Dec 30;280(52):43188-97. Epub 2005 Oct 11.

PMID: 16219765 [PubMed - indexed for MEDLINE]

19:

Regulation of prothymosin alpha gene expression by estrogen in estrogen receptor-containing breast cancer cells via upstream half-palindromic estrogen response element motifs.

Martini PG, Katzenellenbogen BS.

Endocrinology. 2001 Aug;142(8):3493-501.

PMID: 11459795 [PubMed - indexed for MEDLINE]

20:

Regulator of G-protein signalling 2 mRNA is differentially expressed in mammary epithelial subpopulations and over-expressed in the majority of breast cancers.

Smalley MJ, Iravani M, Leao M, Grigoriadis A, Kendrick H, Dexter T, Fenwick K, Regan JL, Britt K, McDonald S, Lord CJ, Mackay A, Ashworth A.

Breast Cancer Res. 2007;9(6):R85.

PMID: 18067675 [PubMed - indexed for MEDLINE]

Related Articles Free article in PMC

Recent Activity